A mammalianized synthetic nitroreductase gene for high-level expression

BACKGROUND: The nitroreductase/5-(azaridin-1-yl)-2,4-dinitrobenzamide (NTR/CB1954) enzyme/prodrug system is considered as a promising candidate for anti-cancer strategies by gene-directed enzyme prodrug therapy (GDEPT) and has recently entered clinical trials. It requires the genetic modification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Grohmann, Maik, Paulmann, Nils, Fleischhauer, Sebastian, Vowinckel, Jakob, Priller, Josef, Walther, Diego J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087338/
https://www.ncbi.nlm.nih.gov/pubmed/19712451
http://dx.doi.org/10.1186/1471-2407-9-301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087338/
https://www.ncbi.nlm.nih.gov/pubmed/19712451
http://dx.doi.org/10.1186/1471-2407-9-301

Ejemplares similares